What this means
This review explains three aging-related ideas and how they may link to rheumatoid arthritis. It says causal proof in people is still limited, and much evidence comes from animal and non-arthritis studies.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of earlier studies
- Kind of research
- A summary of earlier studies
The science
- Original title
- The role of immune aging in rheumatoid arthritis and its clinical and therapeutic significance.
- Authors
- Wei Y, Qi W, Li P et al.
- Journal
- International immunopharmacology
- Published
- Oct 12, 2026
- Study type
- Review
- PMID
- 42863418 ↗
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease, and its onset and progression are closely related to age-related remodeling of the immune system. Immunosenescence refers to age-related changes in the overall structure and function of the immune system; inflammaging is a persistent, low-grade, systemic inflammatory state; cellular senescence refers to a relatively stable cell cycle arrest and functional remodeling of cells under continuous stress. These three are interrelated but correspond to the immune system, systemic inflammatory environment, and cellular state, respectively; therefore, they should not be used interchangeably. In RA, especially elderly-onset RA (EORA), immune age-related changes may occur earlier or be more severe. Human studies on RA mainly support that immune cell lineage remodeling, senescence-associated cell phenotypes, and changes in inflammatory mediators are associated with disease activity, structural damage, and some extra-articular comorbidities. Immunosenescence may compromise T-cell, B-cell, and innate immune functions; concurrently, local cellular senescence and the senescence-associated secretory phenotype (SASP) may drive synovial and bone marrow microenvironment remodeling, while inflammaging may further amplify systemic inflammation. Impaired immune clearance, accumulation of senescent cells, and SASP release may establish a self-perpetuating cycle and are associated with autoantibody production, bone loss, cartilage damage, and cardiovascular and neuropsychiatric comorbidities. However, causal evidence for SASP-driven RA synovitis and the efficacy of senolytic interventions is still primarily derived from experimental arthritis, osteoarthritis, and other non-RA disease models. This article clarifies the definitions and delineates the applicable boundaries of these three terms, reviews their systemic phenotypes, cell lineage characteristics, and molecular basis in RA, especially EORA, analyzes the links between immune age and disease activity, autoantibodies, synovial microenvironment, bone and cartilage damage, and extra-articular manifestations, and evaluates the potential benefits, risks, and evidence limitations of traditional disease-modifying antirheumatic drugs (DMARDs), biologic agents, and emerging senescence-targeting strategies. By constructing an integrated framework covering immune system remodeling, local cellular senescence, inflammatory amplification, and clinical outcomes, this article aims to provide a theoretical basis for further research on EORA risk stratification and immunosenescence-related interventions, rather than directly translating unverified mechanisms into clinical conclusions.
Wei Y, Qi W, Li P et al. The role of immune aging in rheumatoid arthritis and its clinical and therapeutic significance. International immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117531. PMID: 42863418. https://pubmed.ncbi.nlm.nih.gov/42863418/
Related research
A drug pair tested in people with fatty liver disease and scarring
In this small trial, more people on dasatinib plus quercetin had liver scarring improve than those on placebo. The trial was small, and it does not show the drugs are safe or work for everyone.
Old, stuck cells may sometimes help cancer resist treatment
This review looks at how cells that stop dividing after cancer treatment might sometimes help tumors survive. The authors say these cells play a role only in some cases, not in every case.
How cancer treatment may age the heart and blood vessels in breast cancer patients
This review looks at how cancer treatments can leave some cells stuck in an aging state that may harm the heart. It does not prove this process causes heart damage, since other factors can also play a part.
A tea plant root extract killed aging skin cells in a lab dish
Researchers tested a tea root extract on human skin cells that had been made old in a dish. The extract killed more of the old cells than normal ones, and it also cut some inflammation signals. This does not show the extract works in people, because the tests were done in cells and skin samples.
Cell aging after cancer treatment may help or hurt tumour growth
This paper is a review of earlier research on aged cells and cancer. It says these cells may either slow or speed up tumour growth.
A review of how damaged nerves in the body repair their protective coating
This review gathers what is known about how nerve cells rebuild their coating after injury. It does not test a new treatment, and it suggests future treatments may need to be combined.
See all research on Senolytics →